Dean B. Evans
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
- Co-authors
- William R. Miller (21 shared papers)Matthew J. Ellis (8 shared papers)Andrew Coop (3 shared papers)L. Mauriac (2 shared papers)F. Jänicke (3 shared papers)Erhard Quebe‐Fehling (3 shared papers)Mitch Dowsett (10 shared papers)Baljit Singh (1 shared paper)
- Journals
- Journal of Clinical Oncology (14 papers)Cancer Research (13 papers)The Journal of Steroid Biochemistry and Molecular Biology (10 papers)Breast Cancer Research and Treatment (6 papers)Biochemical and Biophysical Research Communications (6 papers)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Dean B. Evans
106 papers receiving 5.5k citations
Dean B. Evans's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 2.0k
- Oncology 2.7k
- Genetics 2.1k
- Reproductive Medicine 297
- Molecular Biology 2.1k
Countries citing papers authored by Dean B. Evans
This map shows the geographic impact of Dean B. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean B. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean B. Evans more than expected).
Fields of papers citing papers by Dean B. Evans
This network shows the impact of papers produced by Dean B. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean B. Evans. The network helps show where Dean B. Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside Dean B. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial Hit paper breakdown → | 2001 | 790 |
| 2 | 2004 | 447 | |
| 3 | 2008 | 445 | |
| 4 | 2005 | 274 | |
| 5 | 2008 | 169 | |
| 6 | Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status. | 2003 | 167 |
| 7 | 2006 | 140 | |
| 8 | 1996 | 117 | |
| 9 | 2007 | 114 | |
| 10 | 2009 | 110 | |
| 11 | 2009 | 108 | |
| 12 | 2008 | 106 | |
| 13 | 2000 | 100 | |
| 14 | 2007 | 97 | |
| 15 | 1990 | 93 | |
| 16 | 2011 | 88 | |
| 17 | 2001 | 84 | |
| 18 | 2007 | 83 | |
| 19 | 2005 | 81 | |
| 20 | 2008 | 80 |
About Dean B. Evans
Dean B. Evans is a scholar working on Genetics, Oncology, Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 107 papers that have together received 5.6k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (53 papers), Breast Cancer Treatment Studies (24 papers), HER2/EGFR in Cancer Research (17 papers), Bone Metabolism and Diseases (10 papers), Cytokine Signaling Pathways and Interactions (9 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Bone health and treatments (8 papers) and Growth Hormone and Insulin-like Growth Factors (8 papers). The work is most often cited by research in Cancer Research (2.0k citations), Oncology (2.7k citations), Genetics (2.1k citations), Reproductive Medicine (297 citations) and Molecular Biology (2.1k citations). Dean B. Evans has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include William R. Miller, Matthew J. Ellis, Andrew Coop, L. Mauriac, F. Jänicke, Erhard Quebe‐Fehling, Mitch Dowsett, Baljit Singh, Margaret Dugan and A.S. Bhatnagar. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The Journal of Steroid Biochemistry and Molecular Biology, Breast Cancer Research and Treatment and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.